Acelyrin Inc.

2.21
0.01 (0.45%)
At close: Apr 17, 2025, 3:59 PM

Acelyrin Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022
Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
-79.03M -48.55M -85.67M -34.97M -95.21M -83.94M -26.04M -176.45M -19.81M -14.41M -14.47M -16.09M
146K -15M 116K 55K 48K 40K 27.00 16K n/a n/a n/a n/a
7.57M 7.05M 10.17M 20.16M 16.36M 15.31M 8.5M 7.14M 1.51M 560K 369K 1.61M
-34.3M 20.66M 2.02M 1.7K -13.16K 23.92M -1.36M 8.24M -1.6M -484K -1.72M -43K
-3.3M -19.75M -3.64M 46K 45K 93K -10.85M 132.75M -811K 16K 62K 1.61M
n/a n/a n/a n/a 4.65M -4.65M n/a n/a n/a n/a n/a n/a
-46.96M -2.52M 32.74M -30.23M 10.05M 34.02M -3.23M 11.23M 1.01M -932K -51K -97K
-121.58M -78.76M -46.27M -57.3M -73.63M -39.13M -31.62M -25.33M -18.09M -14.76M -14.09M -14.57M
-81K -297K -814K -55K -98K -197K -1.76M -10.24M n/a n/a n/a n/a
n/a -7M n/a 7M -10M 10M n/a 10.01M -83K n/a n/a n/a
-252.63M -83.21M -293.96M -198.01M -418.52M -271.88M -266.11M 10M 86.03M -154.88M -107.12M n/a
229.99M 249.38M 205.59M 291.96M 326.02M 137.26M n/a 47.77M -24.34M 147.99M 4.53M n/a
n/a 7M n/a 7M -92.51K -134.61K -266.11M -10M 61.7K -6.89K -107.12M n/a
-22.72M 165.87M -89.18M 100.9M -92.61M -134.81M -267.87M 47.54M 61.61M -6.89M -102.59M n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a 289.00 -289 n/a 8.82K -499 -8.32K n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
1.87M 1.01M -289K 2.81M 2.6M 31K 566.47M -129K -351K 10.64M n/a n/a
1.87M 1.01M -289K 2.81M 2.6M -499K 566.47M -129K -351K 149.64M n/a 124.97M
-142.44M 88.12M -135.75M 46.4M -163.64M -174.43M 266.98M 22.08M 43.17M 127.98M -116.69M 110.4M
-121.66M -79.06M -47.09M -57.35M -73.73M -39.32M -33.38M -35.57M -18.09M -14.76M -14.09M -14.57M